PDLIM4 Antikörper (N-Term)
Kurzübersicht für PDLIM4 Antikörper (N-Term) (ABIN5516869)
Target
Alle PDLIM4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- PDLIM4 Antibody - N-terminal region
-
Sequenz
- VTLRGPSPWG FRLVGGRDFS APLTISRVHA GSKAALAALC PGDLIQAING
-
Aufreinigung
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human PDLIM4
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under AAP77898-100UG
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- prevent freeze-thaw cycles
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
- PDLIM4 (PDZ and LIM Domain 4 (PDLIM4))
-
Andere Bezeichnung
- PDLIM4
-
Hintergrund
-
Background Information: This gene encodes a protein which may be involved in bone development. Mutations in this gene are associated with susceptibility to osteoporosis.
Gene Name: PDZ and LIM domain 4
Alternative Symbols: RIL
Protein Name: PDZ and LIM domain protein 4
-
Molekulargewicht
- 35 kDa
-
Gen-ID
- 8572
-
NCBI Accession
- NP_001124499
-
UniProt
- P50479
Target
-